Jobs / United States / Gilead Sciences INC
Director, US Pricing and Contracting Insights - Cross-portfolio
Gilead Sciences INC · 🇺🇸 United States - California - Foster City
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles5 certified filings for “Assoc Director, R&D Information Systems” (Computer and Information Systems Managers) in CA: $198k–$211k, median $209k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description As the Director of US Pricing and Contracting Insights , within the Market Access Strategy and Insights team, you will be the subject matter expert for US pricing and access insights, leading cross-portfolio pricing workstreams and recommendations to senior leadership, supporting Global Pricing for early/mid-stage assets and Business Development assessments, support TA Pricing and Contracting Teams as needed for late-pipeline/in-line brands, and acting as subject matter expert on current US pricing trends to inform portfolio annual WAC adjustments. This pivotal role demands both strategic vision and hands-on execution. You will navigate complex cross-functional projects and drive impactful results with stakeholders at every level. This role requires leveraging a broad and deep skill set (functional expertise, Gilead portfolio knowledge, communication skills, leadership and influencing, executive presence, etc.) to help drive the success of work across a variety of key stakeholders – including brand and managed markets marketing leads, peer functional leads within Commercial Operations, Global, Government Affairs, Finance, Medical, Corporate Development and executive leadership. This position is based on-site (3-days a week) in Foster City, CA and reports to the Sr. Director, Pricing and Contracting Strategy. As the Director, US Pricing and Contracting Insights you will: • Act as central point of contact to lead US Market Access assumptions, in collaboration with TA-aligned Pricing and Contracting leads, for GlobalPricing Models, including pricing, payer coverage, and GTN implications for early and mid-stage asset, and business development opportunities. • Maintain a record and repository of pricing research and assumptions provided to the Global Team. • Support the transition of Global Pricing work-streams to US Pricing & Contracting leads as molecules move to late-stage pipeline/launch readiness phase (18 month prior to launch). In certain cases, you may support US contract strategy development and planning for assigned products over the different stages of the product life cycle (e.g., launch, post-launch, LOE). Actively engage in Pricing and Contracting Governance Committee process. • Lead primary insights on impact of IRA and PDAB related price-setting methodologies to inform access strategies and assumptions of TA Pricing and Contracting Leads for in-line/late-stage pipeline and Global Pricing for early/mid-stage pipeline. • Act as subject matter expert on current US pricing trends to inform portfolio annual WAC adjustments, IRA and PDAB assumption. • Lead in-line portfoli